What Is the Optimal Bridging Therapy for Patients with Hepatitis C-associated Hepatocellular Carcinoma Awaiting Liver Transplant? An Analysis of the United States HCC Liver Transplantation Consortium
Year: 2022
Type: article
Source: HPB
Institutions: Emory University, University of Cincinnati, University of California, Los Angeles, Johns Hopkins University, Oregon Health & Science University, Indiana University Health, University of Alabama at Birmingham, University of Southern California, Keck Hospital of USC, Cleveland Clinic, The University of Texas Southwestern Medical Center, Stanford Medicine, Tampa General Hospital, Piedmont Atlanta Hospital, Piedmont HealthCare, University of Michigan, University of Wisconsin–Madison, Henry Ford Health, Duke University, University of Pittsburgh Medical Center, Washington University in St. Louis
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4312928274